The following work is half metaphorical ink and half real caffeine
Brewed
(more commonly known: published work)
Cheveldayoff P, Chowdhury F, Shah N, Burow C, Figueiredo M, Nguyen N, Talbo MK, Jamasi R, Katz A, Pasquale C and Hill L. Considerations for
occupational heat exposure: A scoping review. PLOS Climate 2(9):
e0000202
Hill L, Roofigari N, Faraz M, Popov J, Moshkovich M, Figueiredo M,
Hartung E, Talbo MK, Lalanne-Mistrih ML, Sherlock M,
Zachos M, Timmons BW, Obeid J, Pai N. Physical Activity in Pediatric
Inflammatory Bowel Disease: A Scoping Review. Pediatr Exerc Sci. 2023
Jul 24:1-13. doi: 10.1123/pes.2022-0078. Epub ahead of print. PMID:
37487582.
Katz A, Shulkin A, Talbo MK, Housni A, Yardley J,
Brazeau AS, Rabasa-Lhoret R. Hyperglycemia-related anxiety during
competition in an elite athlete with type 1 diabetes: a case report.
Diabetes Metab. 2023 Sep;49(5):101476. doi:
10.1016/j.diabet.2023.101476.
Talbo MK, Katz A, Hill L, Peters TM, Yale JF, Brazeau
AS. Effect of diabetes technologies on the fear of hypoglycaemia among
people living with type 1 diabetes: a systematic review and
meta-analysis. EClinicalMedicine. 2023;62:102119. Published 2023 Aug
4. doi:10.1016/j.eclinm.2023.102119
Talbo MK, Lebbar M, Wu Z, Vanasse A, Lalanne-Mistrih
ML, Brazeau AS, Rabasa-Lhoret R. Gender differences in reported
frequency and consequences of hypoglycemia among adults living with
type 1 diabetes: Results from the BETTER registry. Diabetes Res Clin
Pract. 2023;202:110822. doi:10.1016/j.diabres.2023.110822
Talbo MK, Rabasa-Lhoret R, Yale JF, Peters T, Brazeau
AS. Are nocturnal hypoglycemia prevention strategies influenced by
diabetes technology usage? A BETTER registry analysis. Diabetes
Research and Clinical Practice, September 2022.
Talbo MK, Katz A, Dostie M, Legault L, Brazeau AS.
Associations Between Socioeconomic Status and Patient Experience With
Type 1 Diabetes Management and Complications: Cross-sectional Analysis
of a Cohort From Québec, Canada. Can J Diabetes. 2022
Aug;46(6):569-577.
Talbo MK, Peters T, Brazeau AS, Yale JF,
Rabasa-Lhoret R. Can continuous glucose monitoring technology reduce
fear of hypoglycemia in people with type 1 diabetes? Pol Arch Intern
Med. 2022; 132(2): 16209. doi:10.20452/pamw.16209 (Letter to the
editor)
Katz A, Talbo MK, Xie LF, Nakhla MM, Brazeau AS.
Media Portrayal of Type 1 Diabetes in North American Television and
Film. Canadian Journal of Diabetes, 2022; in press.
Prevost M, Rabasa-Lhoret R, Talbo MK, Yardley J,
Curry E, Brazeau AS. Gender Differences in Strategies to Prevent
Physical Activity–Related Hypoglycemia in Patients with Type 1
Diabetes: A BETTER Study. Diabetes Care. 2022
Brazeau AS, Messier V, Talbo MK, Gagnon C, Taleb N,
Fortier I, Wu Z, Perkins B, Carpentier AC, Bandini A, Rabasa-Lhoret R
on behalf of the BETTER study group. Type 1 Diabetes Population
Surveillance Through the BETTER Patient-Engagement Registry:
Development and Baseline Characteristics. Canadian Journal of
Diabetes. 2022
Talbo MK, Besner ME, Plourde H, Claveau M, Beltempo
M. Association of Caloric Intake, Protein Intake, and Enteral Feeding
Initiation with Weight Gain in Infants Born 32 to 34 Weeks’ Gestation.
American Journal of Perinatology. 2019